Navigation Links
Stanford study highlights cost-effective method of lowering heart disease risks
Date:8/20/2007

STANFORD, Calif. - As U.S. policy experts continue to search for ways to re-engineer the country's health-care system, a new study from the Stanford University School of Medicine shows that a case-management approach helped a diverse group of patients reduce their overall risk of heart disease by roughly 10 percent, and did so in a cost-effective way.

Case management makes use of specially trained health-care personnel, such as nurses and dietitians, who help patients manage chronic conditions on a long-term basis. Case managers handle many of the counseling and tracking roles currently performed by physicians. By divvying up the duties, physicians can devote their attention to patients requiring their specific expertise, while patients get the ongoing counseling and support they need to maintain their health.

"This really is a feasible alternative to the way that we currently organize health care," said lead author Randall Stafford, MD, PhD, associate professor of medicine at the Stanford Prevention Research Center. "Case management makes a lot of sense when it comes to chronic disease because you need to have constant contact with patients to pick up on any problems before they get worse."

The effectiveness of case management in providing preventive medical care and counseling has been explored in previous studies involving middle-class patients, but Stafford said this study is the first to test the approach in a diverse, low-income patient population. The study is published in the fall issue of the journal Disease Management.

According to the Centers for Disease Control and Prevention, chronic diseases - such as heart disease, cancer and diabetes - account for nearly 70 percent of the deaths in the United States, and affect the quality of life of more than 90 million Americans. Many of these diseases can be prevented or controlled through healthy behaviors, such as eating nutritious foods, getting regular exercise and avo
'/>"/>

Contact: Susan Ipaktchian
susani@stanford.edu
650-725-5375
Stanford University Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
2. Apollo And Stanford Team To Train Emergency Medical Technicians
3. Stanford Researchers Identify A Gene Causing Downs Syndrome
4. Transgender Experience - A Tool to Analyze Gender Difference By Stanford Scientist
5. Pharmaceutical Companies Banned from Giving Gifts at Stanford
6. Reddy Asks Stanford University to Open Hyderabad Campus
7. Gene study links endometriosis, infertility
8. Study reveals how stress can make you sick
9. Study points out that HIV vaccine may not be accepted easily
10. A new study surpasses Gene Therapy Hurdle
11. Tomato Sauce reduces Cancer Risk- Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...July 9 /PRNewswire/ -- leViv, Inc. (http://www.le... nutrition and lifestyle programs for,individual h.... The new,programs include 28-days of delicious, d...r 110 items in every order), online recipes, healt...urces, professional advice,news, health informati...
(Date:7/9/2008)... /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE...s to the global life,sciences markets, today annou...mited (AECL) with notice of arbitration proceeding...fulfill its contractual obligations,under its 2006...d if not,granted, seeking significant monetary dam...
(Date:7/9/2008)... adds to its unparalleled content on breastfeeding... professional articles on child, health, from alle...lking., BOULDER, Colo., July 9 /PRNewswire/ -- Br...verything for the New Mom, improves its already,un... doctor-reviewed,professional articles on infant, ...
(Date:7/9/2008)... DRE, Inc., a premier international surgical...mers that as much as $250,000 in medical equipment...lings. , Louisville, KY (...f 2008, in accordance with Tax Code Section 179, c...t bought in 2008. This could make 2008 an attracti...
Breaking Medicine News(10 mins):Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 2Health News:leViv Launches First Meal Programs Specifically Designed for Taste and Health 3Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2
...ced which has been found to have less side effects...mmunotherapy vaccines. //Antibodies against the al...nt encounters the allergen or infection these anti...o counteract the allergen which is an antigen. Co...
...n at University of California, San Francisco have ...innovative devices to first remove and then recons...ccess tumors. // Tumors which are present in the b...cult to operate. The neurosurgeon used a new tec...
...igration/Macrophage Inhibitory factor (MIF) which ...ultiple Sclerosis. This new pathway can be used in...in a way progression of Multiple Sclerosis is hind.... Multiple Sclerosis is an autoimmune disease wh...
...t tiagabine, a selective ?-aminobutyric acid (GABA... and next-morning alertness and performance in adu...mnia is characterized by difficulty initiating or ...sleep, which causes clinically significant distres...
Other Medicine News:Health News:Oral Edible vaccine for Allergy Vaccines 2Health News:Macrophage Inhibitory Factor Causes Multiple Sclerosis Progression 2
(Date:7/6/2008)... BD GeneOhm(TM) Cdiff Assay Submitted for F...Call/ -- BD Diagnostics, a segment,of BD (Becton, ...day the CE,marking of the BD GeneOhm(TM) Cdiff mol...ith Clostridium difficile infection (CDI). It is t...ty, simplicity and speed in one test,procedure. BD...
(Date:7/3/2008)... SAN FRANCISCO, July 3 /- M...hat it will hold a teleconference at 5:00,p.m. EDT...om its,randomized, double-blind, placebo-controlle...ton,s disease., Teleconference/Webcast Details, ... at 5:00 p.m. Eastern,time by telephone, please di...
(Date:7/3/2008)... NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall..."Company") (Amex: SNT ) announced today,that it h...("VGXI") to,supply the plasmid portion of the Comp... 5A gene and siRNA against Factor 5A., Senesco ha... results,using its combination siRNA and plasmid a...
(Date:7/2/2008)... - Top-line Data Expected in Augus... Isolagen(TM), Inc. (Amex:,ILE) announced today th...s,Phase III clinical studies (IT-R-005/006) invest... of nasolabial folds, or wrinkles. The last,person...follow-up visit,and collation of this data has be...
Breaking Medicine Technology:BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 2BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections 3Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 1Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX 28R 29 Phase 2b Trial 3B Drug Shows Statistically Significant Rates of Smoking Cessa 789 7Mexicos expanded health insurance improves hypertension treatment 5750 1Mexicos expanded health insurance improves hypertension treatment 5750 2New research to help fight widespread potato disease 1140 1New research to help fight widespread potato disease 1140 2Pollution from marine vessels linked to heart and lung disease 1137 1Pollution from marine vessels linked to heart and lung disease 1137 2
...evention of Cervical Cancer and Other Human,Papill... of Follow,Up in Large Phase III Clinical Studies ...nd Journal of Medicine publishes the most comprehe...lomavirus vaccine , LYON, France, 10th May2007 &nd...nd sustained efficacy of Gardasil® in the,prev...
... Germany, May 10th, 2007 - Antisense,Pharma today ...minary Results of a Phase I/II-Study in Pancreatic...cinoma with the,TGF-beta2 Inhibitor AP 12009&rdquo... 43rd Annual Meeting of the American Society of,Cl...ago, Illinois,U.S.A, from June 1st - 5th. , In th...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 7Phase I/II-data on Systemic Application of the TGF-beta2-inhibitor,AP 12009 to be Presented 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: